Joe Barton actually said...

"Mr. Chairman, we all understand that antibiotic resistant pathogens are a growing concern not only across the country, but across the globe."

"However, despite these advances, there is still more work that needs to be done."

"I am glad that Congress has been a true leader in this arena."

"A combination of barriers, including, of course, the high cost of drug development and the small profit margins have helped to drive companies out of the anti-infectious space."